Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
Atzeni
Fabiola
F
Leccese
Pietro
P
D'Angelo
Salvatore
S
Sarzi-Puttini
Piercarlo
P
Olivieri
Ignazio
I
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D007871:Leg Ulcer / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000069285:Infliximab; D000068879:Adalimumab; D008727:Methotrexate